[{"edinetCode":"E03356","endDate":"2017\/3\/15","Report abbreviation_x":"asr","context_x":"当期連結時点","numberOfEmployee":2558.0,"averageTemporaryStaff":4314.0,"averageAge":null,"averageYearsOfService":null,"averageAnnualSalary":null,"sharesOwned":12514000.0,"sharesOwendPercent":0.509,"outstandingShares":null,"numberOfSubsidiary":1.0,"bps":3910.07,"equityRatio":0.493,"cashAndCashEquivalents":25685000000.0,"assets":180852000000.0,"currentAssets":64226000000.0,"fixedAsset":116626000000.0,"tangibleFixedAssets":99545000000.0,"intangibleFixedAssets":5608000000.0,"investmentAndOtherAssets":11473000000.0,"liabilities":91753000000.0,"currentLiabilities":60789000000.0,"shorTermDept":null,"currentPortionOfBonds":null,"currentPortionOfLongTermDebt":12349000000.0,"fixedLiabilities":30964000000.0,"bonds":400000000.0,"convertibleBond":null,"commercialPaper":null,"longTermDebts":20741000000.0,"netAsset":89099000000.0,"capitalStock":89034000000.0,"capital":13001000000.0,"capitalSurplus":14888000000.0,"accumulatedEarnings":64622000000.0,"treasuryStock":-3478000000.0,"valuationAndConversionAdjustments":60000000.0,"Report abbreviation_y":"asr","context_y":"当期連結期間","Sales":266423000000.0,"costOfSales":209595000000.0,"grossProfit":56827000000.0,"sgaExpenses":51104000000.0,"salaryAndBenefit":21440000000.0,"depreciationAndSGA":4708000000.0,"RDExpenses":null,"operatingIncome":5723000000.0,"nonOperatingIncome":2177000000.0,"nonOperatingExpenses":837000000.0,"interestExpense":130000000.0,"ordinaryProfit":7062000000.0,"extraordinaryGain":113000000.0,"extraordinaryLoss":1305000000.0,"incomeBeforeTax":5870000000.0,"incomeTaxes":2360000000.0,"netIncome":3510000000.0,"netIncomeAttributableToOwnersOfTheParentCompany":3510000000.0,"comprehensiveIncome":3553000000.0,"eps":153.47,"dilutedEps":153.4,"dividendPerShare":null,"per":20.0,"roe":0.04,"cashFlowFromOperatingActivities":8835000000.0,"depreciationAndCashflowFromOperatingActivities":4888000000.0,"cashFlowFromInvestingActivities":-5241000000.0,"cashFlowFromFinancialActivities":-3681000000.0,"changesInCashAndCashEquivalents":-87000000.0,"列1":"asr","submitDate":"2017\/6\/14","stockCode":2664,"accountingYear":"第50期（自　平成28年３月16日　至　平成29年３月15日）","accountingYearStart":"2016\/3\/16","accountingYearEnd":"2017\/3\/15","accountingStandards":"Japan GAAP","consolidatedAccounting":true,"edinetCode2":"E03356","organizationCategory":"内国法人・組合","listingClassification":"上場","consolidated":"有","capital3":13001,"settlementDate":"2022\/3\/15","submitterName":"株式会社カワチ薬品","submitterNameEnglish":"CAWACHI LIMITED","submitterNameKana":"カブシキガイシャカワチヤクヒン","location":"小山市大字卒島１２９３番地","industory":"小売業","corporateNumber":3060000000000.0},{"edinetCode":"E03356","endDate":"2018\/3\/15","Report abbreviation_x":"asr","context_x":"当期連結時点","numberOfEmployee":2598.0,"averageTemporaryStaff":4289.0,"averageAge":null,"averageYearsOfService":null,"averageAnnualSalary":null,"sharesOwned":12420000.0,"sharesOwendPercent":0.5052,"outstandingShares":null,"numberOfSubsidiary":1.0,"bps":4028.96,"equityRatio":0.501,"cashAndCashEquivalents":25924000000.0,"assets":183303000000.0,"currentAssets":65207000000.0,"fixedAsset":118095000000.0,"tangibleFixedAssets":100986000000.0,"intangibleFixedAssets":5465000000.0,"investmentAndOtherAssets":11642000000.0,"liabilities":91422000000.0,"currentLiabilities":61043000000.0,"shorTermDept":null,"currentPortionOfBonds":400000000.0,"currentPortionOfLongTermDebt":12175000000.0,"fixedLiabilities":30379000000.0,"bonds":null,"convertibleBond":null,"commercialPaper":null,"longTermDebts":19862000000.0,"netAsset":91880000000.0,"capitalStock":91846000000.0,"capital":13001000000.0,"capitalSurplus":14885000000.0,"accumulatedEarnings":67400000000.0,"treasuryStock":-3441000000.0,"valuationAndConversionAdjustments":33000000.0,"Report abbreviation_y":"asr","context_y":"当期連結期間","Sales":268205000000.0,"costOfSales":211068000000.0,"grossProfit":57137000000.0,"sgaExpenses":52563000000.0,"salaryAndBenefit":21931000000.0,"depreciationAndSGA":4771000000.0,"RDExpenses":null,"operatingIncome":4573000000.0,"nonOperatingIncome":2272000000.0,"nonOperatingExpenses":785000000.0,"interestExpense":101000000.0,"ordinaryProfit":6060000000.0,"extraordinaryGain":2000000.0,"extraordinaryLoss":275000000.0,"incomeBeforeTax":5787000000.0,"incomeTaxes":1918000000.0,"netIncome":3869000000.0,"netIncomeAttributableToOwnersOfTheParentCompany":3869000000.0,"comprehensiveIncome":3841000000.0,"eps":169.71,"dilutedEps":null,"dividendPerShare":null,"per":14.9,"roe":0.043,"cashFlowFromOperatingActivities":8600000000.0,"depreciationAndCashflowFromOperatingActivities":4931000000.0,"cashFlowFromInvestingActivities":-6257000000.0,"cashFlowFromFinancialActivities":-2104000000.0,"changesInCashAndCashEquivalents":238000000.0,"列1":"asr","submitDate":"2018\/6\/13","stockCode":2664,"accountingYear":"第51期（自　平成29年３月16日　至　平成30年３月15日）","accountingYearStart":"2017\/3\/16","accountingYearEnd":"2018\/3\/15","accountingStandards":"Japan GAAP","consolidatedAccounting":true,"edinetCode2":"E03356","organizationCategory":"内国法人・組合","listingClassification":"上場","consolidated":"有","capital3":13001,"settlementDate":"2022\/3\/15","submitterName":"株式会社カワチ薬品","submitterNameEnglish":"CAWACHI LIMITED","submitterNameKana":"カブシキガイシャカワチヤクヒン","location":"小山市大字卒島１２９３番地","industory":"小売業","corporateNumber":3060000000000.0},{"edinetCode":"E03356","endDate":"2019\/3\/15","Report abbreviation_x":"asr","context_x":"当期連結時点","numberOfEmployee":2553.0,"averageTemporaryStaff":4162.0,"averageAge":null,"averageYearsOfService":null,"averageAnnualSalary":null,"sharesOwned":12022000.0,"sharesOwendPercent":0.5272,"outstandingShares":null,"numberOfSubsidiary":1.0,"bps":4070.17,"equityRatio":0.507,"cashAndCashEquivalents":28412000000.0,"assets":182944000000.0,"currentAssets":69641000000.0,"fixedAsset":113303000000.0,"tangibleFixedAssets":96947000000.0,"intangibleFixedAssets":4909000000.0,"investmentAndOtherAssets":11446000000.0,"liabilities":90066000000.0,"currentLiabilities":59627000000.0,"shorTermDept":null,"currentPortionOfBonds":null,"currentPortionOfLongTermDebt":11431000000.0,"fixedLiabilities":30439000000.0,"bonds":null,"convertibleBond":null,"commercialPaper":null,"longTermDebts":19677000000.0,"netAsset":92878000000.0,"capitalStock":92837000000.0,"capital":13001000000.0,"capitalSurplus":14885000000.0,"accumulatedEarnings":68391000000.0,"treasuryStock":-3441000000.0,"valuationAndConversionAdjustments":-17000000.0,"Report abbreviation_y":"asr","context_y":"当期連結期間","Sales":264926000000.0,"costOfSales":207731000000.0,"grossProfit":57194000000.0,"sgaExpenses":53307000000.0,"salaryAndBenefit":22177000000.0,"depreciationAndSGA":4785000000.0,"RDExpenses":null,"operatingIncome":3886000000.0,"nonOperatingIncome":2412000000.0,"nonOperatingExpenses":781000000.0,"interestExpense":79000000.0,"ordinaryProfit":5517000000.0,"extraordinaryGain":96000000.0,"extraordinaryLoss":1780000000.0,"incomeBeforeTax":3834000000.0,"incomeTaxes":1817000000.0,"netIncome":2016000000.0,"netIncomeAttributableToOwnersOfTheParentCompany":2016000000.0,"comprehensiveIncome":1965000000.0,"eps":88.44,"dilutedEps":88.38,"dividendPerShare":null,"per":20.9,"roe":0.022,"cashFlowFromOperatingActivities":6684000000.0,"depreciationAndCashflowFromOperatingActivities":4931000000.0,"cashFlowFromInvestingActivities":-1791000000.0,"cashFlowFromFinancialActivities":-2404000000.0,"changesInCashAndCashEquivalents":2487000000.0,"列1":"asr","submitDate":"2019\/6\/12","stockCode":2664,"accountingYear":"第52期（自　2018年３月16日　至　2019年３月15日）","accountingYearStart":"2018\/3\/16","accountingYearEnd":"2019\/3\/15","accountingStandards":"Japan GAAP","consolidatedAccounting":true,"edinetCode2":"E03356","organizationCategory":"内国法人・組合","listingClassification":"上場","consolidated":"有","capital3":13001,"settlementDate":"2022\/3\/15","submitterName":"株式会社カワチ薬品","submitterNameEnglish":"CAWACHI LIMITED","submitterNameKana":"カブシキガイシャカワチヤクヒン","location":"小山市大字卒島１２９３番地","industory":"小売業","corporateNumber":3060000000000.0},{"edinetCode":"E03356","endDate":"2019\/6\/15","Report abbreviation_x":"q1r","context_x":"当四半期会計期間連結時点","numberOfEmployee":null,"averageTemporaryStaff":null,"averageAge":null,"averageYearsOfService":null,"averageAnnualSalary":null,"sharesOwned":null,"sharesOwendPercent":null,"outstandingShares":null,"numberOfSubsidiary":null,"bps":null,"equityRatio":0.496,"cashAndCashEquivalents":null,"assets":185900000000.0,"currentAssets":72491000000.0,"fixedAsset":113409000000.0,"tangibleFixedAssets":96545000000.0,"intangibleFixedAssets":4875000000.0,"investmentAndOtherAssets":11987000000.0,"liabilities":93618000000.0,"currentLiabilities":61352000000.0,"shorTermDept":null,"currentPortionOfBonds":null,"currentPortionOfLongTermDebt":11790000000.0,"fixedLiabilities":32266000000.0,"bonds":null,"convertibleBond":null,"commercialPaper":null,"longTermDebts":21119000000.0,"netAsset":92281000000.0,"capitalStock":92255000000.0,"capital":13001000000.0,"capitalSurplus":14885000000.0,"accumulatedEarnings":68052000000.0,"treasuryStock":-3684000000.0,"valuationAndConversionAdjustments":-31000000.0,"Report abbreviation_y":"q1r","context_y":"当四半期累計期間連結期間","Sales":64937000000.0,"costOfSales":51064000000.0,"grossProfit":13873000000.0,"sgaExpenses":13044000000.0,"salaryAndBenefit":null,"depreciationAndSGA":null,"RDExpenses":null,"operatingIncome":828000000.0,"nonOperatingIncome":326000000.0,"nonOperatingExpenses":96000000.0,"interestExpense":18000000.0,"ordinaryProfit":1057000000.0,"extraordinaryGain":24000000.0,"extraordinaryLoss":12000000.0,"incomeBeforeTax":1069000000.0,"incomeTaxes":383000000.0,"netIncome":686000000.0,"netIncomeAttributableToOwnersOfTheParentCompany":686000000.0,"comprehensiveIncome":672000000.0,"eps":30.14,"dilutedEps":30.11,"dividendPerShare":null,"per":null,"roe":null,"cashFlowFromOperatingActivities":null,"depreciationAndCashflowFromOperatingActivities":null,"cashFlowFromInvestingActivities":null,"cashFlowFromFinancialActivities":null,"changesInCashAndCashEquivalents":null,"列1":"q1r","submitDate":"2019\/7\/25","stockCode":2664,"accountingYear":null,"accountingYearStart":"2019\/3\/16","accountingYearEnd":"2020\/3\/15","accountingStandards":"Japan GAAP","consolidatedAccounting":true,"edinetCode2":"E03356","organizationCategory":"内国法人・組合","listingClassification":"上場","consolidated":"有","capital3":13001,"settlementDate":"2022\/3\/15","submitterName":"株式会社カワチ薬品","submitterNameEnglish":"CAWACHI LIMITED","submitterNameKana":"カブシキガイシャカワチヤクヒン","location":"小山市大字卒島１２９３番地","industory":"小売業","corporateNumber":3060000000000.0},{"edinetCode":"E03356","endDate":"2019\/9\/15","Report abbreviation_x":"q2r","context_x":"当四半期会計期間連結時点","numberOfEmployee":null,"averageTemporaryStaff":null,"averageAge":null,"averageYearsOfService":null,"averageAnnualSalary":null,"sharesOwned":12485000.0,"sharesOwendPercent":0.56,"outstandingShares":null,"numberOfSubsidiary":null,"bps":null,"equityRatio":0.489,"cashAndCashEquivalents":34859000000.0,"assets":189724000000.0,"currentAssets":76578000000.0,"fixedAsset":113145000000.0,"tangibleFixedAssets":96388000000.0,"intangibleFixedAssets":4842000000.0,"investmentAndOtherAssets":11914000000.0,"liabilities":96856000000.0,"currentLiabilities":66868000000.0,"shorTermDept":null,"currentPortionOfBonds":null,"currentPortionOfLongTermDebt":11162000000.0,"fixedLiabilities":29987000000.0,"bonds":null,"convertibleBond":null,"commercialPaper":null,"longTermDebts":18564000000.0,"netAsset":92867000000.0,"capitalStock":92838000000.0,"capital":13001000000.0,"capitalSurplus":14885000000.0,"accumulatedEarnings":69385000000.0,"treasuryStock":-4434000000.0,"valuationAndConversionAdjustments":-35000000.0,"Report abbreviation_y":"q2r","context_y":"当四半期累計期間連結期間","Sales":136478000000.0,"costOfSales":107388000000.0,"grossProfit":29090000000.0,"sgaExpenses":26488000000.0,"salaryAndBenefit":10704000000.0,"depreciationAndSGA":2154000000.0,"RDExpenses":null,"operatingIncome":2602000000.0,"nonOperatingIncome":671000000.0,"nonOperatingExpenses":198000000.0,"interestExpense":35000000.0,"ordinaryProfit":3074000000.0,"extraordinaryGain":54000000.0,"extraordinaryLoss":52000000.0,"incomeBeforeTax":3076000000.0,"incomeTaxes":1056000000.0,"netIncome":2020000000.0,"netIncomeAttributableToOwnersOfTheParentCompany":2020000000.0,"comprehensiveIncome":2002000000.0,"eps":89.49,"dilutedEps":89.43,"dividendPerShare":null,"per":null,"roe":null,"cashFlowFromOperatingActivities":11616000000.0,"depreciationAndCashflowFromOperatingActivities":2217000000.0,"cashFlowFromInvestingActivities":-1741000000.0,"cashFlowFromFinancialActivities":-3428000000.0,"changesInCashAndCashEquivalents":6446000000.0,"列1":"q2r","submitDate":"2019\/10\/28","stockCode":2664,"accountingYear":null,"accountingYearStart":"2019\/3\/16","accountingYearEnd":"2020\/3\/15","accountingStandards":"Japan GAAP","consolidatedAccounting":true,"edinetCode2":"E03356","organizationCategory":"内国法人・組合","listingClassification":"上場","consolidated":"有","capital3":13001,"settlementDate":"2022\/3\/15","submitterName":"株式会社カワチ薬品","submitterNameEnglish":"CAWACHI LIMITED","submitterNameKana":"カブシキガイシャカワチヤクヒン","location":"小山市大字卒島１２９３番地","industory":"小売業","corporateNumber":3060000000000.0},{"edinetCode":"E03356","endDate":"2019\/12\/15","Report abbreviation_x":"q3r","context_x":"当四半期会計期間連結時点","numberOfEmployee":null,"averageTemporaryStaff":null,"averageAge":null,"averageYearsOfService":null,"averageAnnualSalary":null,"sharesOwned":null,"sharesOwendPercent":null,"outstandingShares":null,"numberOfSubsidiary":null,"bps":null,"equityRatio":0.5,"cashAndCashEquivalents":null,"assets":187416000000.0,"currentAssets":74195000000.0,"fixedAsset":113221000000.0,"tangibleFixedAssets":96490000000.0,"intangibleFixedAssets":4827000000.0,"investmentAndOtherAssets":11903000000.0,"liabilities":93628000000.0,"currentLiabilities":62762000000.0,"shorTermDept":200000000.0,"currentPortionOfBonds":null,"currentPortionOfLongTermDebt":11344000000.0,"fixedLiabilities":30866000000.0,"bonds":null,"convertibleBond":null,"commercialPaper":null,"longTermDebts":19272000000.0,"netAsset":93788000000.0,"capitalStock":93742000000.0,"capital":13001000000.0,"capitalSurplus":14885000000.0,"accumulatedEarnings":70289000000.0,"treasuryStock":-4434000000.0,"valuationAndConversionAdjustments":-24000000.0,"Report abbreviation_y":"q3r","context_y":"当四半期累計期間連結期間","Sales":201853000000.0,"costOfSales":158457000000.0,"grossProfit":43395000000.0,"sgaExpenses":39554000000.0,"salaryAndBenefit":null,"depreciationAndSGA":null,"RDExpenses":null,"operatingIncome":3841000000.0,"nonOperatingIncome":1017000000.0,"nonOperatingExpenses":312000000.0,"interestExpense":52000000.0,"ordinaryProfit":4546000000.0,"extraordinaryGain":166000000.0,"extraordinaryLoss":241000000.0,"incomeBeforeTax":4471000000.0,"incomeTaxes":1547000000.0,"netIncome":2924000000.0,"netIncomeAttributableToOwnersOfTheParentCompany":2924000000.0,"comprehensiveIncome":2916000000.0,"eps":130.06,"dilutedEps":129.96,"dividendPerShare":null,"per":null,"roe":null,"cashFlowFromOperatingActivities":null,"depreciationAndCashflowFromOperatingActivities":null,"cashFlowFromInvestingActivities":null,"cashFlowFromFinancialActivities":null,"changesInCashAndCashEquivalents":null,"列1":"q3r","submitDate":"2020\/1\/27","stockCode":2664,"accountingYear":null,"accountingYearStart":"2019\/3\/16","accountingYearEnd":"2020\/3\/15","accountingStandards":"Japan GAAP","consolidatedAccounting":true,"edinetCode2":"E03356","organizationCategory":"内国法人・組合","listingClassification":"上場","consolidated":"有","capital3":13001,"settlementDate":"2022\/3\/15","submitterName":"株式会社カワチ薬品","submitterNameEnglish":"CAWACHI LIMITED","submitterNameKana":"カブシキガイシャカワチヤクヒン","location":"小山市大字卒島１２９３番地","industory":"小売業","corporateNumber":3060000000000.0},{"edinetCode":"E03356","endDate":"2020\/3\/15","Report abbreviation_x":"asr","context_x":"当期連結時点","numberOfEmployee":2616.0,"averageTemporaryStaff":4110.0,"averageAge":null,"averageYearsOfService":null,"averageAnnualSalary":null,"sharesOwned":11782000.0,"sharesOwendPercent":0.5284,"outstandingShares":null,"numberOfSubsidiary":1.0,"bps":4243.64,"equityRatio":0.503,"cashAndCashEquivalents":33105000000.0,"assets":188190000000.0,"currentAssets":75818000000.0,"fixedAsset":112372000000.0,"tangibleFixedAssets":95282000000.0,"intangibleFixedAssets":4790000000.0,"investmentAndOtherAssets":12299000000.0,"liabilities":93491000000.0,"currentLiabilities":63564000000.0,"shorTermDept":null,"currentPortionOfBonds":null,"currentPortionOfLongTermDebt":11096000000.0,"fixedLiabilities":29926000000.0,"bonds":null,"convertibleBond":null,"commercialPaper":null,"longTermDebts":18322000000.0,"netAsset":94699000000.0,"capitalStock":94640000000.0,"capital":13001000000.0,"capitalSurplus":14885000000.0,"accumulatedEarnings":71187000000.0,"treasuryStock":-4434000000.0,"valuationAndConversionAdjustments":-18000000.0,"Report abbreviation_y":"asr","context_y":"当期連結期間","Sales":270313000000.0,"costOfSales":211601000000.0,"grossProfit":58711000000.0,"sgaExpenses":53035000000.0,"salaryAndBenefit":22448000000.0,"depreciationAndSGA":4461000000.0,"RDExpenses":null,"operatingIncome":5675000000.0,"nonOperatingIncome":1310000000.0,"nonOperatingExpenses":412000000.0,"interestExpense":68000000.0,"ordinaryProfit":6573000000.0,"extraordinaryGain":196000000.0,"extraordinaryLoss":988000000.0,"incomeBeforeTax":5782000000.0,"incomeTaxes":1959000000.0,"netIncome":3822000000.0,"netIncomeAttributableToOwnersOfTheParentCompany":3822000000.0,"comprehensiveIncome":3821000000.0,"eps":170.36,"dilutedEps":170.23,"dividendPerShare":null,"per":10.4,"roe":0.041,"cashFlowFromOperatingActivities":12159000000.0,"depreciationAndCashflowFromOperatingActivities":4587000000.0,"cashFlowFromInvestingActivities":-3718000000.0,"cashFlowFromFinancialActivities":-3747000000.0,"changesInCashAndCashEquivalents":4693000000.0,"列1":"asr","submitDate":"2020\/6\/12","stockCode":2664,"accountingYear":"第53期（自　2019年３月16日　至　2020年３月15日）","accountingYearStart":"2019\/3\/16","accountingYearEnd":"2020\/3\/15","accountingStandards":"Japan GAAP","consolidatedAccounting":true,"edinetCode2":"E03356","organizationCategory":"内国法人・組合","listingClassification":"上場","consolidated":"有","capital3":13001,"settlementDate":"2022\/3\/15","submitterName":"株式会社カワチ薬品","submitterNameEnglish":"CAWACHI LIMITED","submitterNameKana":"カブシキガイシャカワチヤクヒン","location":"小山市大字卒島１２９３番地","industory":"小売業","corporateNumber":3060000000000.0},{"edinetCode":"E03356","endDate":"2020\/6\/15","Report abbreviation_x":"q1r","context_x":"当四半期会計期間連結時点","numberOfEmployee":null,"averageTemporaryStaff":null,"averageAge":null,"averageYearsOfService":null,"averageAnnualSalary":null,"sharesOwned":null,"sharesOwendPercent":null,"outstandingShares":null,"numberOfSubsidiary":null,"bps":null,"equityRatio":0.484,"cashAndCashEquivalents":null,"assets":197996000000.0,"currentAssets":86654000000.0,"fixedAsset":111341000000.0,"tangibleFixedAssets":94284000000.0,"intangibleFixedAssets":4794000000.0,"investmentAndOtherAssets":12262000000.0,"liabilities":102115000000.0,"currentLiabilities":68199000000.0,"shorTermDept":null,"currentPortionOfBonds":null,"currentPortionOfLongTermDebt":12071000000.0,"fixedLiabilities":33916000000.0,"bonds":null,"convertibleBond":null,"commercialPaper":null,"longTermDebts":22187000000.0,"netAsset":95881000000.0,"capitalStock":95797000000.0,"capital":13001000000.0,"capitalSurplus":14885000000.0,"accumulatedEarnings":72345000000.0,"treasuryStock":-4434000000.0,"valuationAndConversionAdjustments":2000000.0,"Report abbreviation_y":"q1r","context_y":"当四半期累計期間連結期間","Sales":73757000000.0,"costOfSales":57391000000.0,"grossProfit":16365000000.0,"sgaExpenses":13225000000.0,"salaryAndBenefit":null,"depreciationAndSGA":null,"RDExpenses":null,"operatingIncome":3140000000.0,"nonOperatingIncome":355000000.0,"nonOperatingExpenses":101000000.0,"interestExpense":17000000.0,"ordinaryProfit":3394000000.0,"extraordinaryGain":null,"extraordinaryLoss":161000000.0,"incomeBeforeTax":3232000000.0,"incomeTaxes":1072000000.0,"netIncome":2160000000.0,"netIncomeAttributableToOwnersOfTheParentCompany":2160000000.0,"comprehensiveIncome":2181000000.0,"eps":96.91,"dilutedEps":96.85,"dividendPerShare":null,"per":null,"roe":null,"cashFlowFromOperatingActivities":null,"depreciationAndCashflowFromOperatingActivities":null,"cashFlowFromInvestingActivities":null,"cashFlowFromFinancialActivities":null,"changesInCashAndCashEquivalents":null,"列1":"q1r","submitDate":"2020\/7\/27","stockCode":2664,"accountingYear":null,"accountingYearStart":"2020\/3\/16","accountingYearEnd":"2021\/3\/15","accountingStandards":"Japan GAAP","consolidatedAccounting":true,"edinetCode2":"E03356","organizationCategory":"内国法人・組合","listingClassification":"上場","consolidated":"有","capital3":13001,"settlementDate":"2022\/3\/15","submitterName":"株式会社カワチ薬品","submitterNameEnglish":"CAWACHI LIMITED","submitterNameKana":"カブシキガイシャカワチヤクヒン","location":"小山市大字卒島１２９３番地","industory":"小売業","corporateNumber":3060000000000.0},{"edinetCode":"E03356","endDate":"2020\/9\/15","Report abbreviation_x":"q2r","context_x":"当四半期会計期間連結時点","numberOfEmployee":null,"averageTemporaryStaff":null,"averageAge":null,"averageYearsOfService":null,"averageAnnualSalary":null,"sharesOwned":12303000.0,"sharesOwendPercent":0.5515,"outstandingShares":null,"numberOfSubsidiary":null,"bps":null,"equityRatio":0.496,"cashAndCashEquivalents":48393000000.0,"assets":198352000000.0,"currentAssets":87606000000.0,"fixedAsset":110745000000.0,"tangibleFixedAssets":93724000000.0,"intangibleFixedAssets":4819000000.0,"investmentAndOtherAssets":12200000000.0,"liabilities":99980000000.0,"currentLiabilities":68482000000.0,"shorTermDept":null,"currentPortionOfBonds":null,"currentPortionOfLongTermDebt":11355000000.0,"fixedLiabilities":31498000000.0,"bonds":null,"convertibleBond":null,"commercialPaper":null,"longTermDebts":19608000000.0,"netAsset":98371000000.0,"capitalStock":98282000000.0,"capital":13001000000.0,"capitalSurplus":14898000000.0,"accumulatedEarnings":74795000000.0,"treasuryStock":-4413000000.0,"valuationAndConversionAdjustments":11000000.0,"Report abbreviation_y":"q2r","context_y":"当四半期累計期間連結期間","Sales":148549000000.0,"costOfSales":115347000000.0,"grossProfit":33201000000.0,"sgaExpenses":26660000000.0,"salaryAndBenefit":10976000000.0,"depreciationAndSGA":2056000000.0,"RDExpenses":null,"operatingIncome":6541000000.0,"nonOperatingIncome":687000000.0,"nonOperatingExpenses":212000000.0,"interestExpense":33000000.0,"ordinaryProfit":7016000000.0,"extraordinaryGain":26000000.0,"extraordinaryLoss":210000000.0,"incomeBeforeTax":6831000000.0,"incomeTaxes":2220000000.0,"netIncome":4611000000.0,"netIncomeAttributableToOwnersOfTheParentCompany":4611000000.0,"comprehensiveIncome":4642000000.0,"eps":206.8,"dilutedEps":206.66,"dividendPerShare":null,"per":null,"roe":null,"cashFlowFromOperatingActivities":15525000000.0,"depreciationAndCashflowFromOperatingActivities":2114000000.0,"cashFlowFromInvestingActivities":-803000000.0,"cashFlowFromFinancialActivities":565000000.0,"changesInCashAndCashEquivalents":15287000000.0,"列1":"q2r","submitDate":"2020\/10\/26","stockCode":2664,"accountingYear":null,"accountingYearStart":"2020\/3\/16","accountingYearEnd":"2021\/3\/15","accountingStandards":"Japan GAAP","consolidatedAccounting":true,"edinetCode2":"E03356","organizationCategory":"内国法人・組合","listingClassification":"上場","consolidated":"有","capital3":13001,"settlementDate":"2022\/3\/15","submitterName":"株式会社カワチ薬品","submitterNameEnglish":"CAWACHI LIMITED","submitterNameKana":"カブシキガイシャカワチヤクヒン","location":"小山市大字卒島１２９３番地","industory":"小売業","corporateNumber":3060000000000.0},{"edinetCode":"E03356","endDate":"2020\/12\/15","Report abbreviation_x":"q3r","context_x":"当四半期会計期間連結時点","numberOfEmployee":null,"averageTemporaryStaff":null,"averageAge":null,"averageYearsOfService":null,"averageAnnualSalary":null,"sharesOwned":null,"sharesOwendPercent":null,"outstandingShares":null,"numberOfSubsidiary":null,"bps":null,"equityRatio":0.507,"cashAndCashEquivalents":null,"assets":196938000000.0,"currentAssets":85756000000.0,"fixedAsset":111182000000.0,"tangibleFixedAssets":94183000000.0,"intangibleFixedAssets":4825000000.0,"investmentAndOtherAssets":12173000000.0,"liabilities":96938000000.0,"currentLiabilities":67672000000.0,"shorTermDept":null,"currentPortionOfBonds":null,"currentPortionOfLongTermDebt":10658000000.0,"fixedLiabilities":29266000000.0,"bonds":null,"convertibleBond":null,"commercialPaper":null,"longTermDebts":17187000000.0,"netAsset":99999000000.0,"capitalStock":99924000000.0,"capital":13001000000.0,"capitalSurplus":14899000000.0,"accumulatedEarnings":76434000000.0,"treasuryStock":-4411000000.0,"valuationAndConversionAdjustments":-1000000.0,"Report abbreviation_y":"q3r","context_y":"当四半期累計期間連結期間","Sales":216078000000.0,"costOfSales":167401000000.0,"grossProfit":48676000000.0,"sgaExpenses":39947000000.0,"salaryAndBenefit":null,"depreciationAndSGA":null,"RDExpenses":null,"operatingIncome":8728000000.0,"nonOperatingIncome":1039000000.0,"nonOperatingExpenses":318000000.0,"interestExpense":48000000.0,"ordinaryProfit":9449000000.0,"extraordinaryGain":31000000.0,"extraordinaryLoss":216000000.0,"incomeBeforeTax":9265000000.0,"incomeTaxes":3015000000.0,"netIncome":6250000000.0,"netIncomeAttributableToOwnersOfTheParentCompany":6250000000.0,"comprehensiveIncome":6267000000.0,"eps":280.24,"dilutedEps":280.05,"dividendPerShare":null,"per":null,"roe":null,"cashFlowFromOperatingActivities":null,"depreciationAndCashflowFromOperatingActivities":null,"cashFlowFromInvestingActivities":null,"cashFlowFromFinancialActivities":null,"changesInCashAndCashEquivalents":null,"列1":"q3r","submitDate":"2021\/1\/25","stockCode":2664,"accountingYear":null,"accountingYearStart":"2020\/3\/16","accountingYearEnd":"2021\/3\/15","accountingStandards":"Japan GAAP","consolidatedAccounting":true,"edinetCode2":"E03356","organizationCategory":"内国法人・組合","listingClassification":"上場","consolidated":"有","capital3":13001,"settlementDate":"2022\/3\/15","submitterName":"株式会社カワチ薬品","submitterNameEnglish":"CAWACHI LIMITED","submitterNameKana":"カブシキガイシャカワチヤクヒン","location":"小山市大字卒島１２９３番地","industory":"小売業","corporateNumber":3060000000000.0},{"edinetCode":"E03356","endDate":"2021\/3\/15","Report abbreviation_x":"asr","context_x":"当期連結時点","numberOfEmployee":2703.0,"averageTemporaryStaff":4123.0,"averageAge":null,"averageYearsOfService":null,"averageAnnualSalary":null,"sharesOwned":11512000.0,"sharesOwendPercent":0.516,"outstandingShares":null,"numberOfSubsidiary":1.0,"bps":4517.46,"equityRatio":0.519,"cashAndCashEquivalents":41235000000.0,"assets":194100000000.0,"currentAssets":82796000000.0,"fixedAsset":111303000000.0,"tangibleFixedAssets":93924000000.0,"intangibleFixedAssets":4918000000.0,"investmentAndOtherAssets":12460000000.0,"liabilities":93243000000.0,"currentLiabilities":65037000000.0,"shorTermDept":null,"currentPortionOfBonds":null,"currentPortionOfLongTermDebt":10259000000.0,"fixedLiabilities":28205000000.0,"bonds":null,"convertibleBond":null,"commercialPaper":null,"longTermDebts":16151000000.0,"netAsset":100857000000.0,"capitalStock":100782000000.0,"capital":13001000000.0,"capitalSurplus":14899000000.0,"accumulatedEarnings":77293000000.0,"treasuryStock":-4411000000.0,"valuationAndConversionAdjustments":-2000000.0,"Report abbreviation_y":"asr","context_y":"当期連結期間","Sales":284492000000.0,"costOfSales":219813000000.0,"grossProfit":64678000000.0,"sgaExpenses":54117000000.0,"salaryAndBenefit":23039000000.0,"depreciationAndSGA":4358000000.0,"RDExpenses":null,"operatingIncome":10560000000.0,"nonOperatingIncome":1441000000.0,"nonOperatingExpenses":420000000.0,"interestExpense":61000000.0,"ordinaryProfit":11581000000.0,"extraordinaryGain":42000000.0,"extraordinaryLoss":987000000.0,"incomeBeforeTax":10636000000.0,"incomeTaxes":3527000000.0,"netIncome":7109000000.0,"netIncomeAttributableToOwnersOfTheParentCompany":7109000000.0,"comprehensiveIncome":7125000000.0,"eps":318.73,"dilutedEps":318.49,"dividendPerShare":null,"per":9.2,"roe":0.073,"cashFlowFromOperatingActivities":15267000000.0,"depreciationAndCashflowFromOperatingActivities":4473000000.0,"cashFlowFromInvestingActivities":-3152000000.0,"cashFlowFromFinancialActivities":-3984000000.0,"changesInCashAndCashEquivalents":8129000000.0,"列1":"asr","submitDate":"2021\/6\/11","stockCode":2664,"accountingYear":"第54期（自　2020年３月16日　至　2021年３月15日）","accountingYearStart":"2020\/3\/16","accountingYearEnd":"2021\/3\/15","accountingStandards":"Japan GAAP","consolidatedAccounting":true,"edinetCode2":"E03356","organizationCategory":"内国法人・組合","listingClassification":"上場","consolidated":"有","capital3":13001,"settlementDate":"2022\/3\/15","submitterName":"株式会社カワチ薬品","submitterNameEnglish":"CAWACHI LIMITED","submitterNameKana":"カブシキガイシャカワチヤクヒン","location":"小山市大字卒島１２９３番地","industory":"小売業","corporateNumber":3060000000000.0},{"edinetCode":"E03356","endDate":"2021\/6\/15","Report abbreviation_x":"q1r","context_x":"当四半期会計期間連結時点","numberOfEmployee":null,"averageTemporaryStaff":null,"averageAge":null,"averageYearsOfService":null,"averageAnnualSalary":null,"sharesOwned":null,"sharesOwendPercent":null,"outstandingShares":null,"numberOfSubsidiary":null,"bps":null,"equityRatio":0.512,"cashAndCashEquivalents":null,"assets":197298000000.0,"currentAssets":86839000000.0,"fixedAsset":110458000000.0,"tangibleFixedAssets":93179000000.0,"intangibleFixedAssets":4857000000.0,"investmentAndOtherAssets":12421000000.0,"liabilities":96120000000.0,"currentLiabilities":66020000000.0,"shorTermDept":null,"currentPortionOfBonds":null,"currentPortionOfLongTermDebt":10626000000.0,"fixedLiabilities":30099000000.0,"bonds":null,"convertibleBond":null,"commercialPaper":null,"longTermDebts":17870000000.0,"netAsset":101178000000.0,"capitalStock":101058000000.0,"capital":13001000000.0,"capitalSurplus":14901000000.0,"accumulatedEarnings":77542000000.0,"treasuryStock":-4387000000.0,"valuationAndConversionAdjustments":-6000000.0,"Report abbreviation_y":"q1r","context_y":"当四半期累計期間連結期間","Sales":70216000000.0,"costOfSales":54630000000.0,"grossProfit":15585000000.0,"sgaExpenses":13689000000.0,"salaryAndBenefit":null,"depreciationAndSGA":null,"RDExpenses":null,"operatingIncome":1896000000.0,"nonOperatingIncome":320000000.0,"nonOperatingExpenses":91000000.0,"interestExpense":14000000.0,"ordinaryProfit":2125000000.0,"extraordinaryGain":null,"extraordinaryLoss":35000000.0,"incomeBeforeTax":2089000000.0,"incomeTaxes":725000000.0,"netIncome":1364000000.0,"netIncomeAttributableToOwnersOfTheParentCompany":1364000000.0,"comprehensiveIncome":1359000000.0,"eps":61.16,"dilutedEps":61.05,"dividendPerShare":null,"per":null,"roe":null,"cashFlowFromOperatingActivities":null,"depreciationAndCashflowFromOperatingActivities":null,"cashFlowFromInvestingActivities":null,"cashFlowFromFinancialActivities":null,"changesInCashAndCashEquivalents":null,"列1":"q1r","submitDate":"2021\/7\/28","stockCode":2664,"accountingYear":null,"accountingYearStart":"2021\/3\/16","accountingYearEnd":"2022\/3\/15","accountingStandards":"Japan GAAP","consolidatedAccounting":true,"edinetCode2":"E03356","organizationCategory":"内国法人・組合","listingClassification":"上場","consolidated":"有","capital3":13001,"settlementDate":"2022\/3\/15","submitterName":"株式会社カワチ薬品","submitterNameEnglish":"CAWACHI LIMITED","submitterNameKana":"カブシキガイシャカワチヤクヒン","location":"小山市大字卒島１２９３番地","industory":"小売業","corporateNumber":3060000000000.0},{"edinetCode":"E03356","endDate":"2021\/9\/15","Report abbreviation_x":"q2r","context_x":"当四半期会計期間連結時点","numberOfEmployee":null,"averageTemporaryStaff":null,"averageAge":null,"averageYearsOfService":null,"averageAnnualSalary":null,"sharesOwned":12584000.0,"sharesOwendPercent":0.5638,"outstandingShares":null,"numberOfSubsidiary":null,"bps":null,"equityRatio":0.518,"cashAndCashEquivalents":47295000000.0,"assets":198874000000.0,"currentAssets":88524000000.0,"fixedAsset":110349000000.0,"tangibleFixedAssets":93041000000.0,"intangibleFixedAssets":4937000000.0,"investmentAndOtherAssets":12370000000.0,"liabilities":95801000000.0,"currentLiabilities":67768000000.0,"shorTermDept":null,"currentPortionOfBonds":null,"currentPortionOfLongTermDebt":9947000000.0,"fixedLiabilities":28033000000.0,"bonds":null,"convertibleBond":null,"commercialPaper":null,"longTermDebts":15661000000.0,"netAsset":103072000000.0,"capitalStock":102949000000.0,"capital":13001000000.0,"capitalSurplus":14901000000.0,"accumulatedEarnings":79433000000.0,"treasuryStock":-4387000000.0,"valuationAndConversionAdjustments":-3000000.0,"Report abbreviation_y":"q2r","context_y":"当四半期累計期間連結期間","Sales":144384000000.0,"costOfSales":112231000000.0,"grossProfit":32153000000.0,"sgaExpenses":27694000000.0,"salaryAndBenefit":11313000000.0,"depreciationAndSGA":2078000000.0,"RDExpenses":null,"operatingIncome":4458000000.0,"nonOperatingIncome":698000000.0,"nonOperatingExpenses":201000000.0,"interestExpense":27000000.0,"ordinaryProfit":4955000000.0,"extraordinaryGain":null,"extraordinaryLoss":46000000.0,"incomeBeforeTax":4909000000.0,"incomeTaxes":1653000000.0,"netIncome":3256000000.0,"netIncomeAttributableToOwnersOfTheParentCompany":3256000000.0,"comprehensiveIncome":3254000000.0,"eps":145.91,"dilutedEps":145.65,"dividendPerShare":null,"per":null,"roe":null,"cashFlowFromOperatingActivities":9728000000.0,"depreciationAndCashflowFromOperatingActivities":2131000000.0,"cashFlowFromInvestingActivities":-1750000000.0,"cashFlowFromFinancialActivities":-1917000000.0,"changesInCashAndCashEquivalents":6060000000.0,"列1":"q2r","submitDate":"2021\/10\/27","stockCode":2664,"accountingYear":null,"accountingYearStart":"2021\/3\/16","accountingYearEnd":"2022\/3\/15","accountingStandards":"Japan GAAP","consolidatedAccounting":true,"edinetCode2":"E03356","organizationCategory":"内国法人・組合","listingClassification":"上場","consolidated":"有","capital3":13001,"settlementDate":"2022\/3\/15","submitterName":"株式会社カワチ薬品","submitterNameEnglish":"CAWACHI LIMITED","submitterNameKana":"カブシキガイシャカワチヤクヒン","location":"小山市大字卒島１２９３番地","industory":"小売業","corporateNumber":3060000000000.0},{"edinetCode":"E03356","endDate":"2021\/12\/15","Report abbreviation_x":"q3r","context_x":"当四半期会計期間連結時点","numberOfEmployee":null,"averageTemporaryStaff":null,"averageAge":null,"averageYearsOfService":null,"averageAnnualSalary":null,"sharesOwned":null,"sharesOwendPercent":null,"outstandingShares":null,"numberOfSubsidiary":null,"bps":null,"equityRatio":0.537,"cashAndCashEquivalents":null,"assets":194290000000.0,"currentAssets":83918000000.0,"fixedAsset":110372000000.0,"tangibleFixedAssets":93088000000.0,"intangibleFixedAssets":4955000000.0,"investmentAndOtherAssets":12327000000.0,"liabilities":89841000000.0,"currentLiabilities":63752000000.0,"shorTermDept":100000000.0,"currentPortionOfBonds":null,"currentPortionOfLongTermDebt":9312000000.0,"fixedLiabilities":26088000000.0,"bonds":null,"convertibleBond":null,"commercialPaper":null,"longTermDebts":13546000000.0,"netAsset":104449000000.0,"capitalStock":104328000000.0,"capital":13001000000.0,"capitalSurplus":14901000000.0,"accumulatedEarnings":80812000000.0,"treasuryStock":-4387000000.0,"valuationAndConversionAdjustments":-5000000.0,"Report abbreviation_y":"q3r","context_y":"当四半期累計期間連結期間","Sales":211498000000.0,"costOfSales":164104000000.0,"grossProfit":47393000000.0,"sgaExpenses":41135000000.0,"salaryAndBenefit":null,"depreciationAndSGA":null,"RDExpenses":null,"operatingIncome":6258000000.0,"nonOperatingIncome":1052000000.0,"nonOperatingExpenses":303000000.0,"interestExpense":39000000.0,"ordinaryProfit":7007000000.0,"extraordinaryGain":null,"extraordinaryLoss":57000000.0,"incomeBeforeTax":6949000000.0,"incomeTaxes":2314000000.0,"netIncome":4634000000.0,"netIncomeAttributableToOwnersOfTheParentCompany":4634000000.0,"comprehensiveIncome":4631000000.0,"eps":207.68,"dilutedEps":207.32,"dividendPerShare":null,"per":null,"roe":null,"cashFlowFromOperatingActivities":null,"depreciationAndCashflowFromOperatingActivities":null,"cashFlowFromInvestingActivities":null,"cashFlowFromFinancialActivities":null,"changesInCashAndCashEquivalents":null,"列1":"q3r","submitDate":"2022\/1\/28","stockCode":2664,"accountingYear":null,"accountingYearStart":"2021\/3\/16","accountingYearEnd":"2022\/3\/15","accountingStandards":"Japan GAAP","consolidatedAccounting":true,"edinetCode2":"E03356","organizationCategory":"内国法人・組合","listingClassification":"上場","consolidated":"有","capital3":13001,"settlementDate":"2022\/3\/15","submitterName":"株式会社カワチ薬品","submitterNameEnglish":"CAWACHI LIMITED","submitterNameKana":"カブシキガイシャカワチヤクヒン","location":"小山市大字卒島１２９３番地","industory":"小売業","corporateNumber":3060000000000.0}]